FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064601> ?p ?o ?g. }

• W2064601 abstract "Diffuse large B-cell lymphoma (DLBCL) is a clinically and genetically heterogeneous disease, accounting for 30% of all non-Hodgkin lymphoma cases. Although the addition of rituximab to standard treatment (CHOP: cyclophosphamide, doxorubicin, vincristine, and prednisone) has increased survival of DLBCL patients, 30-40% of patients still relapse. Moreover, 1-10% of the relapsed patients show central nervous system (CNS) involvement which is almost always a fatal condition. Consequently, further studies are needed to understand the molecular mechanisms involved in the disease and to develop novel therapies to improve the patients? outcome. In this regard, modeling the disease in mice has reached a great relevance and it is necessary to develop novel models that represent the clinical features of the disseminated disease. In addition, novel biomarkers are needed to predict DLBCL outcome. Accumulating data have emerged about the correlation of CXCR4 receptor with disease dissemination and aggressiveness in several neoplasms. This receptor has also been described to play a role in the migration and trafficking of B cells and some hematological malignancies. However, no data are available about its involvement in DLBCL dissemination or its relevance as a prognostic marker in this disease. The goals of the current thesis were: 1) To develop bioluminescent mouse models of disseminated DLBCL which reflect this human pathology. 2) To evaluate the in vivo antitumor effect of a new inhibitor of focal adhesion signaling, E7123, in a model of DLBCL with central nervous system (CNS) involvement. And, 3) To study the role of CXCR4 receptor in the migration and dissemination of DLBCL cells and evaluated the expression of the receptor in lymph node biopsies of DLBCL patients and its prognostic value. We have developed bioluminescent xenograft models of disseminated DLBCL that derive from DLBCL cell lines and that reflect this human pathology. These models can be used to study cell dissemination and the effect of novel antitumor drugs against DLBCL. In fact, the focal adhesion inhibitor E7123 was tested in a disseminated DLBCL model with CNS involvement; this drug delayed the growth of DLBCL metastasis to the CNS and increased mouse survival time. These findings suggest that E7123 was able to cross the blood brain barrier and thus could be effective for the treatment of DLBCL patients with CNS involvement. However, further preclinical development and clinical assays will be necessary to evaluate E7123 antitumor effect in relapsed DLBCL patients. In addition, we observed that the level of membrane CXCR4 expression in DLBCL cell lines correlated positively with in vitro migration towards SDF-1? chemokine and this migration was inhibited by the CXCR4 antagonist, AMD3100. Expression of the receptor was also associated with increased engraftment and dissemination, and decreased survival time in DLBCL NOD/SCID mouse models. Moreover, the subcutaneous preconditioning of DLBCL cells produced changes in the levels of membrane CXCR4 that correlated with aggressiveness of the models; higher levels of CXCR4 led to shortened mouse survival and enhanced lymphoma dissemination. Furthermore, administration of the AMD3100 antagonist to a xenograft DLBCL model decreased dissemination of the tumor cells. Thus, AMD3100 could potentially be used in the treatment of DLBCL. We also evaluated the prognostic value of CXCR4 and found that the receptor is an independent prognostic factor associated with a decreased progression-free survival of patients. These results show that CXCR4 mediates dissemination of DLBCL cells and define for the first time its value as an independent prognostic marker in patients. This novel prognostic marker requires further studies and validation in an independent cohort of DLBCL patients to be used as a potentially clinical tool." @default.
• W2064601 created "2016-06-24" @default.
• W2064601 creator A5015083903 @default.
• W2064601 creator A5017769450 @default.
• W2064601 date "2014-06-10" @default.
• W2064601 modified "2023-09-24" @default.
• W2064601 title "Development of diffuse large B-celllymphoma mouse models and role of CXCR4 in dissemination = Desarrollo de modelos murinos de linfoma difuso de células grandes B y papel de CXCR4 en diseminación" @default.
• W2064601 hasPublicationYear "2014" @default.
• W2064601 type Work @default.
• W2064601 sameAs 2064601 @default.
• W2064601 citedByCount "0" @default.
• W2064601 crossrefType "dissertation" @default.
• W2064601 hasAuthorship W2064601A5015083903 @default.
• W2064601 hasAuthorship W2064601A5017769450 @default.
• W2064601 hasConcept C126322002 @default.
• W2064601 hasConcept C129470790 @default.
• W2064601 hasConcept C13373296 @default.
• W2064601 hasConcept C143998085 @default.
• W2064601 hasConcept C170493617 @default.
• W2064601 hasConcept C203014093 @default.
• W2064601 hasConcept C2776694085 @default.
• W2064601 hasConcept C2776755627 @default.
• W2064601 hasConcept C2778559949 @default.
• W2064601 hasConcept C2779338263 @default.
• W2064601 hasConcept C2779429289 @default.
• W2064601 hasConcept C2780653079 @default.
• W2064601 hasConcept C502942594 @default.
• W2064601 hasConcept C71924100 @default.
• W2064601 hasConcept C86803240 @default.
• W2064601 hasConceptScore W2064601C126322002 @default.
• W2064601 hasConceptScore W2064601C129470790 @default.
• W2064601 hasConceptScore W2064601C13373296 @default.
• W2064601 hasConceptScore W2064601C143998085 @default.
• W2064601 hasConceptScore W2064601C170493617 @default.
• W2064601 hasConceptScore W2064601C203014093 @default.
• W2064601 hasConceptScore W2064601C2776694085 @default.
• W2064601 hasConceptScore W2064601C2776755627 @default.
• W2064601 hasConceptScore W2064601C2778559949 @default.
• W2064601 hasConceptScore W2064601C2779338263 @default.
• W2064601 hasConceptScore W2064601C2779429289 @default.
• W2064601 hasConceptScore W2064601C2780653079 @default.
• W2064601 hasConceptScore W2064601C502942594 @default.
• W2064601 hasConceptScore W2064601C71924100 @default.
• W2064601 hasConceptScore W2064601C86803240 @default.
• W2064601 hasLocation W20646011 @default.
• W2064601 hasOpenAccess W2064601 @default.
• W2064601 hasPrimaryLocation W20646011 @default.
• W2064601 hasRelatedWork W1890069836 @default.
• W2064601 hasRelatedWork W1955256573 @default.
• W2064601 hasRelatedWork W1970403599 @default.
• W2064601 hasRelatedWork W1975829668 @default.
• W2064601 hasRelatedWork W2030443579 @default.
• W2064601 hasRelatedWork W2048389563 @default.
• W2064601 hasRelatedWork W2058809815 @default.
• W2064601 hasRelatedWork W2113826821 @default.
• W2064601 hasRelatedWork W2229843211 @default.
• W2064601 hasRelatedWork W2268823596 @default.
• W2064601 hasRelatedWork W2464077425 @default.
• W2064601 hasRelatedWork W2554780652 @default.
• W2064601 hasRelatedWork W2777637880 @default.
• W2064601 hasRelatedWork W2784393223 @default.
• W2064601 hasRelatedWork W2982603593 @default.
• W2064601 hasRelatedWork W2990047716 @default.
• W2064601 hasRelatedWork W3116256776 @default.
• W2064601 hasRelatedWork W3126300349 @default.
• W2064601 hasRelatedWork W3195275355 @default.
• W2064601 hasRelatedWork W3207186915 @default.
• W2064601 isParatext "false" @default.
• W2064601 isRetracted "false" @default.
• W2064601 magId "2064601" @default.
• W2064601 workType "dissertation" @default.